Autonomix Medical, Inc. (AMIX) research
Autonomix Medical, Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $3.78
- As of
Autonomix Medical, Inc. (AMIX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-16.
As of . Source: SEC EDGAR filings for AMIX. Method and limitations.
Share the AMIX intelligence card
See the full AMIX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AMIX on one page. Preview it with sample data, then open it live with a free account.
Preview the AMIX dossierActive signals for AMIX
- mediumEARNINGS_BEAT
Q1-2027: Beat consensus by 23.2%, EPS $-5.02 vs $-6.5331 estimate
- mediumEARNINGS_BEAT
Q3-2026: Beat consensus by 39.7% - EPS $-7.56 vs $-12.5307 estimate
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 13.3% - EPS $-4.83 vs $-5.5692 estimate
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 13.3% - EPS $-0.23 vs $-0.2652 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 43.7% - EPS $-1.81 vs $-1.2597 estimate
FREE, NO ACCOUNT
Every signal on AMIX, as it fires
You are seeing 5 of 8 signals recorded on AMIX since 2026-05-16.
The five above landed across 4 days. The other 3 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, AMIX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
AMIX against its peers
AMIX's return on equity of -283.5% ranks in the 16th percentile of 15 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | AMIX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 0.0 USD | 2.7M USD | 6 | 17 |
| Revenue YoY | n/a | -14.4% | n/a | 5 |
| Gross margin | n/a | 36.5% | n/a | 15 |
| Operating margin | n/a | -268.4% | n/a | 13 |
| Net margin | n/a | -238.9% | n/a | 16 |
| Return on equity | -283.5% | -143.5% | 16 | 15 |
Peers (20): ICCM, CODX, VNRX, WOK, TANAF, NVNO, INBS, PMI, AIDX, IRIX, BMRA, ITOC, ALRTF, USAQ, STME, AEMD, CTSO, SINT, PLSM, ADGM. Left out: SONX (period gap), KLYG (no annual filing), TRIB (period gap), NMTC (no annual filing), PMEDF (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AMIX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more AMIX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to AMIXand get the insider, 13F, options, and confluence read in one view.